Galmed Pharmaceuticals Ltd.
GLMD
$1.55
-$0.08-4.91%
NASDAQ
03/31/2025 | 12/31/2024 | 06/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | 13.41% | -59.18% | 29.76% | 29.76% | 30.33% |
Total Depreciation and Amortization | -- | -100.00% | 722.22% | 722.22% | 12.50% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -49.35% | 1,435.29% | 700.00% | 700.00% | -5.52% |
Change in Net Operating Assets | 80.36% | -159.11% | -145.54% | -145.54% | -1,894.44% |
Cash from Operations | 36.23% | -119.27% | 25.60% | 25.60% | -7.96% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -153.47% | -255.73% | 97.45% | 97.45% | -68.02% |
Cash from Investing | -153.47% | -255.73% | 97.45% | 97.45% | -68.02% |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -- | -- | -- | -- | -- |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 108.30% | -467.13% | 156.65% | 156.65% | -306.40% |